Arkolith/Insider Trading/ETON/Form 4

Opaleye Management Inc.

10% OwnerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Sep 12, 2024
Net Buying
Open-Market Buys
$505K
Open-Market Sells
$0
Net Open-Market Flow
$505K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)5K$4.75$24K75K
Sep 11, 2024Buy(P)45K$4.75$214K2.7M
Sep 10, 2024Buy(P)50K$4.65$233K2.7M
Sep 10, 2024Buy(P)8K$4.65$35K70K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-036104) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML